Dr Regu logo Dr ReguClinical Library Browse the Library
Home / Library / Clinical Pathways / STI Treatment & Partner Notification
Clinical Pathway

STI Treatment & Partner Notification

First-line regimens, counselling & notification duties

Field: Infectious DiseasesCode: ID-03BUpdated: June 2026Reference: sti.guidelines.org.au (ASHM)
Check the current dose before you prescribe. Gonorrhoea ceftriaxone dosing, the syphilis benzathine penicillin supply, and the HPV vaccine schedule have all changed recently — this sheet reflects current ASHM guidance, not the doses many of us learned.

First-line treatment regimens

  • Chlamydia (genital): doxycycline 100mg BD for 7 days; pregnancy — azithromycin 1g PO stat; symptomatic rectal infection — doxycycline for 21 days.
  • Gonorrhoea (genital/anorectal): ceftriaxone 500mg IM (with lignocaine) stat + azithromycin 1g PO stat.
  • Gonorrhoea (pharyngeal): same ceftriaxone 500mg IM, but azithromycin increases to 2g PO (1g stat then 1g 6–12 hours later); test of cure at 2 weeks.
  • Genital herpes: valaciclovir 500mg BD for 5–10 days (first episode) or 3 days (recurrence, self-initiated); suppression 500mg daily, reviewed 6-monthly.
  • Genital warts: patient-applied podophyllotoxin or imiquimod 5% cream are both first-line; cryotherapy is the clinician-applied alternative.
Syphilis — dose & current supply alert. Early syphilis: benzathine penicillin 1.8g (2.4 million units) IM as a single dose (two injections). Late/unknown duration: same dose weekly for 3 doses; neurosyphilis is specialist-led. Bicillin L-A is currently in shortage (both syringe strengths) — a TGA-approved overseas product is available, and a doxycycline-based alternative exists for non-pregnant patients who cannot access benzathine penicillin. Confirm current status and the alternative regimen at sti.guidelines.org.au before prescribing.

HSV & HPV — counselling

  • Asymptomatic HSV shedding is common — most transmission happens between recognised episodes; daily suppression reduces partner transmission.
  • HSV in pregnancy: start suppression from 36 weeks in those with known recurrent HSV; a primary infection in the third trimester needs urgent specialist input.
  • HPV vaccine: Gardasil 9 is now a single dose on the National Immunisation Program (age 12–13), with catch-up to 25 — any age if HIV-positive or immunocompromised.
  • Cervical screening: 5-yearly HPV test from age 25–74 (self-collection now available); annual if HIV-positive.

Contact tracing & notifiable duty

  • Trace sexual contacts of the last 6 months for chlamydia/gonorrhoea; for syphilis the window is stage-dependent (commonly 3 months primary, 6 months secondary, 12 months early latent) — confirm via sti.guidelines.org.au.
  • Let Them Know (letthemknow.org.au) supports anonymous SMS/email partner notification.
  • Chlamydia, gonorrhoea, syphilis and HIV are all notifiable — in Victoria, in writing within 5 days; confirm your own state's process.
  • Consider presumptive treatment of a recent, known sexual contact of confirmed chlamydia/gonorrhoea, particularly if follow-up is uncertain.

Safety

  • Confirm current ceftriaxone/azithromycin doses before prescribing — gonorrhoea dosing has changed; don't rely on memory.
  • Check the live syphilis-treatment supply alert at sti.guidelines.org.au before assuming benzathine penicillin is available.
  • Don't delay empirical treatment of a high-risk symptomatic contact while awaiting results.

Red flags / refer

  • Pregnancy with a new STI diagnosis, primary genital herpes in the third trimester, or syphilis in pregnancy → urgent specialist/obstetric co-management.
  • Neurosyphilis, disseminated gonococcal infection, or treatment failure → sexual health physician or infectious diseases.
  • Possible doxy-PEP candidate (e.g. recurrent bacterial STIs in GBMSM) → discuss with a sexual health physician — the 2023/24 ASHM consensus statement supports selective, time-limited use, reviewed periodically.

ID-03B v1.0 · Reviewed Jun 2026 · Review Jun 2027

For health-professional use. Framework: ASHM/Australian STI Management Guidelines, Australian Immunisation Handbook. Companion sheet: ID-03 STI Screening & Testing. MSHC (03) 9341 6200; Sexual Health Victoria 1800 013 952.